Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • HealthAssure to invest...

    HealthAssure to invest 15 million dollars to strengthen business

    Written by Ruby Khatun Khatun Published On 13 Jan 2018 4:45 AM  |  Updated On 13 Jan 2018 4:45 AM
    HealthAssure to invest 15 million dollars to strengthen business

    New Delhi: HealthAssure, a health-tech platform, said it will invest USD 15 million (over Rs 95 crore) over the next three years to strengthen its primary care network in the country.


    Started in 2011, HealthAssure provides access to 3,100 primary care centres across 1,000 cities and connects insurers and corporates through its platform.


    "We plan to invest USD 15 million over the next three years. This will go towards network enrichment, the creation of more products, strengthening IT infrastructure and distribution," HealthAssure founder and CEO Varun Gera told PTI.


    He added that by 2020, it expects to reach 2.5-3 million customers.


    The company currently has serviced one million customers through their B2B model. It works with companies like Apollo Munich, Max Bupa, Cigna, ICICI Prudential, Royal Sundram, Loreal, FedEx, Deloitte, Max Life, among others.


    Gera said the company, which has already hit profits, is also looking at exploring international markets.


    "We are looking at entering the Middle East market within the next six months. We are also exploring markets like Hong Kong and Singapore," he added.


    Gera said international business is expected to account for almost half of its business in the next 2-3 years.

    Apollo MunichcignaDeloitteFedExhealth-tech platformHealthAssureICICI Prudentialinternational marketsinvestL'OrealMax BupaMax Lifeprimary care networkRoyal Sundramstrengthen businessVarun Gera
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok